MENU
SLXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Silexion Therapeutics (SLXN) Earnings Date & Reports
Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS)... Show more
A.I. Advisor
published Earnings
SLXN is expected to report earnings to rise 835.71% to -1310 cents per share on August 18
Q2'26
Est.
$-13.10
Q4'25
Missed
by $1.15
Q3'25
Missed
by $2.63
The last earnings report on March 17 showed earnings per share of -139 cents, missing the estimate of -25 cents. With 36.40K shares outstanding, the current market capitalization sits at 1.31M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information